[HTML] from plos.orgC Vavricka, Q Han, Y Huang, SM Erickson… - PloS one, 2011 - dx.plos.org ... variants of the dopa decarboxylase and alpha-methyldopa hypersensitive loci in Drosophila. Genetics 112: 249–265. Find this article online; Sparrow JC, Wright TR (1974) The selection for mutants in Drosophila melanogaster hypersensitive to alpha-methyldopa, a dopa... Related articles - Cached - All 6 versions
P Dill, J Schneider, P Weber, D Trachsel… - Molecular Genetics and …, 2011 - Elsevier ... the age of 8 years. In contrast to the previously published patients with a FOLR1 gene defect, our patient presented with an abnormal L-dopa metabolism in CSF and high 3-O-methyl-dopa. Upon oral treatment with folinic acid ...
W Vongpatanasin, K Kario… - The Journal of Clinical …, 2011 - Wiley Online Library ... In hypertensive patients, methyldopa reduces BP mainly by reducing TPR with minimal effects on heart rate or cardiac output.23 Although once a mainstay of antihypertensive therapy, a-methyl- dopa is currently used mainly in pregnant women with hypertension because of ... Cited by 1
G Horn - US Patent 20,110,152,271, 2011 - freepatentsonline.com ... 2. The composition of claim 1, wherein said selective α-2 adrenergic receptor agonist is selected from the group consisting of lofexidine, apraclonidine, mivazerol, clonidine, brimonidine, alpha methyldopa, guanfacine, dexmedetomidine, (+)-S)-4-[1-(2,3-dimethyl-phenyl)-ethyl ... Cached
SK Moccelini, AC Franzoi, IC Vieira… - Biosensors and …, 2011 - Elsevier ...Methyldopa (2-amino-3-(3,4-dihydroxyphenyl)-2-methyl-propanoic acid) is a catechol derivative (catecholamine) widely used as an antihypertensive agent. It can be converted to 1-methyl dopamine and 1-methyl norepinephrine (Talebpour et al., 2004). ... All 3 versions